scispace - formally typeset
V

Volkmar Falk

Researcher at Charité

Publications -  916
Citations -  97746

Volkmar Falk is an academic researcher from Charité. The author has contributed to research in topics: Medicine & Aortic valve. The author has an hindex of 93, co-authored 801 publications receiving 85653 citations. Previous affiliations of Volkmar Falk include University of Göttingen & Intuitive Surgical.

Papers
More filters
Journal ArticleDOI

Does Reasonable Incomplete Surgical Revascularization Affect Early or Long-Term Survival in Patients With Multivessel Coronary Artery Disease Receiving Left Internal Mammary Artery Bypass to Left Anterior Descending Artery?

TL;DR: In presence of left internal mammary artery-to-left anterior descending artery bypass, reasonable IR of the circumflex or right coronary artery territory did not adversely affect early or long-term survival in patients with multivessel CAD; however, IR is a good therapeutic option and the benefit of CR should be balanced against the risks.
Journal ArticleDOI

Seven-Year Follow-up After Minimally Invasive Direct Coronary Artery Bypass: Experience With More Than 1300 Patients

TL;DR: MIDCAB can be safely performed with low postoperative mortality and morbidity as well as freedom from major adverse cardiac and cerebral events and angina compare favorably with stenting and conventional surgery.
Journal ArticleDOI

Diagnosis and Treatment Algorithm for Blood Flow Obstructions in Patients With Left Ventricular Assist Device.

TL;DR: This study analyzed experience with obstruction of blood flow through the LVAD with the purpose of developing optimal diagnosis and treatment of LVAD-related thrombosis, and developed an algorithm for optimal diagnoses and treatment.
Journal ArticleDOI

Frailty is a predictor of short- and mid-term mortality after elective cardiac surgery independently of age

TL;DR: CAF and FORECAST are additional tools to evaluate elderly patients adequately before elective cardiac surgery, and showed an association with short- and mid-term mortality independently of age.
Journal ArticleDOI

Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity

TL;DR: An unmet clinical need remains for valve replacements with regenerative, remodelling and growth potential, and next-generation tissue-engineered heart valves (TEHVs) are a promising therapeutic option for patients with valvular heart disease.